Personal information

Verified email addresses

Verified email domains

Activities

Works (9)

Beszámoló a IV. Áramlási Citometriai Napról

Hematológia–Transzfuziológia
2023-12-15 | Journal article
Contributors: Gábor Barna; Gábor Szalóki
Source: check_circle
Crossref

Targeting Melanoma-Associated Fibroblasts (MAFs) with Activated γδ (Vδ2) T Cells: An In Vitro Cytotoxicity Model

International Journal of Molecular Sciences
2023-08-17 | Journal article
Contributors: Anna Hajdara; Uğur Çakır; Barbara Érsek; Pálma Silló; Balázs Széky; Gábor Barna; Shaaban Faqi; Miklós Gyöngy; Sarolta Kárpáti; Krisztián Németh et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Landscape of BCL2 Resistance Mutations in a Real-World Cohort of Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Treated with Venetoclax

International Journal of Molecular Sciences
2023-03-18 | Journal article
Contributors: Lili Kotmayer; Tamás László; Gábor Mikala; Richárd Kiss; Luca Lévay; Lajos László Hegyi; Stefánia Gróf; Tibor Nagy; Gábor Barna; Péter Farkas et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Folic Acid Treatment Directly Influences the Genetic and Epigenetic Regulation along with the Associated Cellular Maintenance Processes of HT-29 and SW480 Colorectal Cancer Cell Lines

Cancers
2022-04 | Journal article | Author
Contributors: Sára Zsigrai; Alexandra Kalmár; Barbara K. Barták; Zsófia B. Nagy; Krisztina A. Szigeti; Gábor Valcz; William Kothalawala; Titanilla Dankó; Anna Sebestyén; Gabor Barna et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

Limitations of VS38c labeling in the detection of plasma cell myeloma by flow cytometry

Cytometry Part A
2022-02 | Journal article
Contributors: Ágnes Czeti; Gábor Szalóki; Gergely Varga; Virág Réka Szita; Zsolt István Komlósi; Ferenc Takács; Ágnes Márk; Botond Timár; András Matolcsy; Gábor Barna
Source: check_circle
Crossref

An Extensive Quality Control and Quality Assurance (QC/QA) Program Significantly Improves Inter-Laboratory Concordance Rates of Flow-Cytometric Minimal Residual Disease Assessment in Acute Lymphoblastic Leukemia: An I-BFM-FLOW-Network Report

Cancers
2021-12 | Journal article | Author
Contributors: Margarita Maurer-Granofszky; Angela Schumich; Barbara Buldini; Giuseppe Gaipa; Janos Kappelmayer; Ester Mejstrikova; Leonid Karawajew; Jorge Rossi; Adın Çınar Suzan; Evangelina Agriello et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Lenalidomide abrogates the survival effect of bone marrow stromal cells in chronic lymphocytic leukemia

Hematological Oncology
2021-10 | Journal article
Contributors: Csilla Kriston; Márk Hernádfői; Márk Plander; Ágnes Márk; Ferenc Takács; Ágnes Czeti; Gábor Szalóki; Orsolya Szabó; András Matolcsy; Gábor Barna
Source: check_circle
Crossref

Screening and monitoring of the BTKC481S mutation in a real‐world cohort of patients with relapsed/refractory chronic lymphocytic leukaemia during ibrutinib therapy

British Journal of Haematology
2021-07 | Journal article
Contributors: Csaba Bödör; Lili Kotmayer; Tamás László; Ferenc Takács; Gábor Barna; Richárd Kiss; Endre Sebestyén; Tibor Nagy; Lajos László Hegyi; Gábor Mikala et al.
Source: check_circle
Crossref

Identification of a novel resistance mechanism in venetoclax treatment and its prediction in chronic lymphocytic leukemia

Acta Oncologica
2021-04-03 | Journal article
Contributors: Ferenc Takács; Gábor Mikala; Noémi Nagy; Andrea Reszegi; Ágnes Czeti; Gábor Szalóki; Gábor Barna
Source: check_circle
Crossref

Peer review (9 reviews for 5 publications/grants)

Review activity for Annals of hematology. (2)
Review activity for Cancer drug resistance. (2)
Review activity for International journal of obesity. (1)
Review activity for Leukemia (1)
Review activity for Pathology oncology research (3)